Wall Street Zen Downgrades Wellgistics Health (NASDAQ:WGRX) to Sell

Wellgistics Health (NASDAQ:WGRX) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Wellgistics Health Stock Performance

NASDAQ:WGRX opened at $1.50 on Friday. The company has a quick ratio of 0.11, a current ratio of 0.32 and a debt-to-equity ratio of 11.16. The business has a fifty day moving average of $1.04. Wellgistics Health has a 12 month low of $0.62 and a 12 month high of $7.04.

Wellgistics Health (NASDAQ:WGRX) last released its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $7.79 million for the quarter.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.